Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
SHORT...
There is a chance for as much as a 60% increase in as little as 37 days, based on T.A and news/rumors circling the company. The news around the company as well as dates for specific events to occur line up almost EXACTLY with what the T.A would lead me to believe.
There is a chance for as much as a 70% increase in as little as 22 days, based on T.A and news/rumors circling the company. The news around the company as well as dates for specific events to occur line up almost EXACTLY with what the T.A would lead me to believe.
Could potentially see as much as a 70% increase in as soon as the next 22 days huge buy opportunity, not just because of technical analysis but the news surrounding the company is almost EXACTLY in sync with where it looks to be going.
